SHARMA, Rohini, ALHARBI, Sultan N., ELLUM, Ksenia, MOTEDAYEN AVAL, Leila, CASADEI-GARDINI, Andrea, PINATO, David James, BETTINGER, Dominik, BENGSCH, Bertram, PATEL, Rishi und EVANS, Joanne, 2025. Deep sequencing of circulating tumour DNA as a biomarker of clinical outcome to transarterial chemoembolisation in hepatocellular carcinoma. Freiburg: Universität.

Sharma, R., Alharbi, S.N., Ellum, K., Motedayen Aval, L., Casadei-Gardini, A., Pinato, D.J., Bettinger, D., Bengsch, B., Patel, R., Evans, J., 2025. Deep sequencing of circulating tumour DNA as a biomarker of clinical outcome to transarterial chemoembolisation in hepatocellular carcinoma. Universität, Freiburg. https://doi.org/10.1038/s41698-025-00961-2

Sharma, R., Alharbi, S. N., Ellum, K., Motedayen Aval, L., Casadei-Gardini, A., Pinato, D. J., Bettinger, D., Bengsch, B., Patel, R., & Evans, J. (ca. 2025). Deep sequencing of circulating tumour DNA as a biomarker of clinical outcome to transarterial chemoembolisation in hepatocellular carcinoma [Cd]. Universität. https://doi.org/10.1038/s41698-025-00961-2

Sharma R, Alharbi SN, Ellum K, Motedayen Aval L, Casadei-Gardini A, Pinato DJ, Bettinger D, Bengsch B, Patel R, Evans J (2025) Deep sequencing of circulating tumour DNA as a biomarker of clinical outcome to transarterial chemoembolisation in hepatocellular carcinoma. Universität, Freiburg

Sharma, Rohini/ Alharbi, Sultan N./ Ellum, Ksenia/ Motedayen Aval, Leila/ Casadei-Gardini, Andrea/ Pinato, David James/ Bettinger, Dominik/ Bengsch, Bertram/ Patel, Rishi/ Evans, Joanne, Deep sequencing of circulating tumour DNA as a biomarker of clinical outcome to transarterial chemoembolisation in hepatocellular carcinoma, Freiburg 2025.